J B Epstein

Summary

Affiliation: British Columbia
Country: Canada

Publications

  1. ncbi Periodontal disease and periodontal management in patients with cancer
    J B Epstein
    British Columbia Cancer Agency, Vancouver Hospital and Health Sciences Centre, 600 West 10th Avenue, Vancouver, BC, Canada V5Z 4E6
    Oral Oncol 37:613-9. 2001
  2. ncbi The effect of a disinfectant/coolant irrigant on microbes isolated from dental unit water lines
    Joel B Epstein
    Department of Dentistry, Vancouver Hospital and Health Sciences Centre, British Columbia, Canada
    Spec Care Dentist 22:137-41. 2002
  3. ncbi The role of salivary function in modulating chemotherapy-induced oropharyngeal mucositis: a review of the literature
    Joel B Epstein
    Department of Dentistry, Vancouver Hospital and Health Sciences Centre, 855 West 12th Avenue, Vancouver, British Columbia, Canada V5Z 1R9
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94:39-44. 2002
  4. ncbi Fluconazole mouthrinses for oral candidiasis in postirradiation, transplant, and other patients
    Joel B Epstein
    Vancouver Hospital and Health Sciences Centre, British Columbia, Canada
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93:671-5. 2002
  5. ncbi Characteristics of oral and paraoral malignant lymphoma: a population-based review of 361 cases
    J B Epstein
    Department of Dentistry, British Columbia Cancer Agency, Vancouver, Canada
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92:519-25. 2001
  6. ncbi Oral topical doxepin rinse: analgesic effect in patients with oral mucosal pain due to cancer or cancer therapy
    J B Epstein
    Department of Dentistry, Vancouver Hospital and Health Sciences Centre, Vancouver, BC, Canada
    Oral Oncol 37:632-7. 2001
  7. ncbi Quality of life and oral function in patients treated with radiation therapy for head and neck cancer
    J B Epstein
    British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia, Canada V5Z 4E6
    Head Neck 23:389-98. 2001
  8. ncbi The correlation between epidermal growth factor levels in saliva and the severity of oral mucositis during oropharyngeal radiation therapy
    J B Epstein
    Department of Dentistry, Vancouver Hospital and Health Sciences Center, British Columbia, Canada
    Cancer 89:2258-65. 2000
  9. ncbi Topical azathioprine in the treatment of immune-mediated chronic oral inflammatory conditions: a series of cases
    J B Epstein
    Vancouver Hospital and Health Sciences Centre, British Columbia Cancer Agency, University of British Columbia, Vancouver, Canada
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91:56-61. 2001
  10. ncbi Impact of localized treatment in reducing risk of progression of low-grade oral dysplasia: molecular evidence of incomplete resection
    L Zhang
    Faculty of Dentistry, University of British Columbia, 2199 Wesbrook Mall, BC, V6T 1Z3, Vancouver, Canada
    Oral Oncol 37:505-12. 2001

Collaborators

Detail Information

Publications77

  1. ncbi Periodontal disease and periodontal management in patients with cancer
    J B Epstein
    British Columbia Cancer Agency, Vancouver Hospital and Health Sciences Centre, 600 West 10th Avenue, Vancouver, BC, Canada V5Z 4E6
    Oral Oncol 37:613-9. 2001
    ....
  2. ncbi The effect of a disinfectant/coolant irrigant on microbes isolated from dental unit water lines
    Joel B Epstein
    Department of Dentistry, Vancouver Hospital and Health Sciences Centre, British Columbia, Canada
    Spec Care Dentist 22:137-41. 2002
    ..The potential for contamination of the lines from patients' saliva may have been reduced due to use of anti-retraction valves and the disinfectant/sterile water irrigation, as conducted in this study...
  3. ncbi The role of salivary function in modulating chemotherapy-induced oropharyngeal mucositis: a review of the literature
    Joel B Epstein
    Department of Dentistry, Vancouver Hospital and Health Sciences Centre, 855 West 12th Avenue, Vancouver, British Columbia, Canada V5Z 1R9
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94:39-44. 2002
    ....
  4. ncbi Fluconazole mouthrinses for oral candidiasis in postirradiation, transplant, and other patients
    Joel B Epstein
    Vancouver Hospital and Health Sciences Centre, British Columbia, Canada
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93:671-5. 2002
    ..The purpose of the present study was to evaluate the clinical efficacy of fluconazole aqueous mouthrinses to treat oral candidiasis...
  5. ncbi Characteristics of oral and paraoral malignant lymphoma: a population-based review of 361 cases
    J B Epstein
    Department of Dentistry, British Columbia Cancer Agency, Vancouver, Canada
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92:519-25. 2001
    ..Waldeyer's ring is the most common site of lymphomas involving the oral region. The purpose of this study was to review the characteristics of a large series of malignant lymphoma of the oral region...
  6. ncbi Oral topical doxepin rinse: analgesic effect in patients with oral mucosal pain due to cancer or cancer therapy
    J B Epstein
    Department of Dentistry, Vancouver Hospital and Health Sciences Centre, Vancouver, BC, Canada
    Oral Oncol 37:632-7. 2001
    ..The results of this single dose trial suggest that topical doxepin rinse has significant ability to provide clinically significant pain relief in patients with mucosal damage with an extended duration of effect...
  7. ncbi Quality of life and oral function in patients treated with radiation therapy for head and neck cancer
    J B Epstein
    British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia, Canada V5Z 4E6
    Head Neck 23:389-98. 2001
    ..The purpose of this investigation was to assess the quality of life, oral function, and oral symptoms in a cohort of patients during and after radiation therapy...
  8. ncbi The correlation between epidermal growth factor levels in saliva and the severity of oral mucositis during oropharyngeal radiation therapy
    J B Epstein
    Department of Dentistry, Vancouver Hospital and Health Sciences Center, British Columbia, Canada
    Cancer 89:2258-65. 2000
    ..The purpose of this study was to assess the relation between salivary EGF and the severity of oral mucositis in patients with carcinoma of the head and neck during radiation therapy...
  9. ncbi Topical azathioprine in the treatment of immune-mediated chronic oral inflammatory conditions: a series of cases
    J B Epstein
    Vancouver Hospital and Health Sciences Centre, British Columbia Cancer Agency, University of British Columbia, Vancouver, Canada
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91:56-61. 2001
    ..The purpose of this study was to evaluate the efficacy of topical AZA in chronic oral GVHD and in oral autoimmune diseases in a series of patients...
  10. ncbi Impact of localized treatment in reducing risk of progression of low-grade oral dysplasia: molecular evidence of incomplete resection
    L Zhang
    Faculty of Dentistry, University of British Columbia, 2199 Wesbrook Mall, BC, V6T 1Z3, Vancouver, Canada
    Oral Oncol 37:505-12. 2001
    ..Our data also suggest that currently an inadequate margin may in part be responsible for the high rate of recurrence, especially in high-risk lesions...
  11. ncbi A clinical trial of bethanechol in patients with xerostomia after radiation therapy. A pilot study
    J B Epstein
    Division of Oral Medicine and Clinical Dentistry, Vancouver General Hospital, British Columbia, Canada
    Oral Surg Oral Med Oral Pathol 77:610-4. 1994
    ..003) and whole stimulated saliva (p = 0.001) were seen. In patients with pretreatment stimulated saliva volumes greater than resting saliva volumes, a positive response to subsequent use of the sialagogue was seen...
  12. ncbi Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation
    J B Epstein
    Leukemia Bone Marrow Transplantation Program of British Columbia, Vancouver Hospital and University of British Columbia, Vancouver, BC, Canada
    Bone Marrow Transplant 30:785-92. 2002
    ..The EORTC QLQ C-30 questionnaire with the oral addendum provides a measure of the quality of life and oral function, and may provide useful outcome measures for assessment of oral care prevention and management in HCT patients...
  13. ncbi Classifications of oral lesions in HIV infection
    N Narani
    University of British Columbia, Vancouver, Canada
    J Clin Periodontol 28:137-45. 2001
    ..CONCLUSION: Only through such recognition can appropriate definitive diagnostic testing be conducted, and appropriate therapeutic intervention for the oral condition and the systemic condition be considered...
  14. ncbi Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomized, double-blind, placebo-controlled clinical trial
    J B Epstein
    British Columbia Cancer Agency, Vancouver Hospital and Health Sciences Centre, University of British Columbia, Vancouver, BC V5Z 4E6, Canada
    Cancer 92:875-85. 2001
    ....
  15. ncbi A survey of antibiotic use in dentistry
    J B Epstein
    Department of Dentistry, Vancouver Hospital and Health Sciences Centre, British Columbia, Canada
    J Am Dent Assoc 131:1600-9. 2000
    ..As a result of the increase in antimicrobial resistance, the authors conducted a survey to assess current antibiotic use in dental practice...
  16. ncbi Comparison of HPV infection, p53 mutation and allelic losses in post-transplant and non-posttransplant oral squamous cell carcinomas
    L Zhang
    Faculty of Dentistry, University of British Columbia, Canada
    J Oral Pathol Med 31:134-41. 2002
    ..Oral squamous cell carcinoma (SCC) is increasingly found in transplant recipients, although little is known of the natural history of the disease or the mechanism underlying this increase...
  17. ncbi Assessment of objectives of post-doctoral general dentistry programs in Canada
    J B Epstein
    Department of Dentistry, Vancouver Hospital and Health Sciences Centre, 855 West 12th Avenue, Vancouver, BC V5Z 1M9, Canada
    Spec Care Dentist 20:191-4. 2000
    ..The findings support continuing reciprocity in accreditation standards between the Canadian and American Commissions on Dental Education and Dental Accreditation...
  18. ncbi Permanent vision loss in one eye following administration of local anesthesia for a dental extraction
    B Rishiraj
    Vancouver General Hospital, 855 W 12th Ave, Vancouver, BC, Canada V5Z Im9
    Int J Oral Maxillofac Surg 34:220-3. 2005
    ..This will possibly prevent intravascular injection, which can lead to fluid emboli occluding the ophthalmic artery with the devastating result of vision loss...
  19. ncbi Reliability of histologic diagnosis of clinically normal intraoral tissue adjacent to clinically suspicious lesions in former upper aerodigestive tract cancer patients
    Dena J Fischer
    Department of Oral Medicine, School of Dentistry, University of Washington, Box 356370, Seattle, WA 98195 6370, USA
    Oral Oncol 41:489-96. 2005
    ..82 (95% CI 0.72, 0.91)]. Histologic diagnosis of subsets of clinically normal oral specimens adjacent to suspicious tissue has low reliability. Molecular techniques may improve diagnoses in these subsets...
  20. ncbi Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome
    Lewei Zhang
    Faculty of Dentistry, University of British Columbia, Vancouver, Canada
    Cancer Res 65:8017-21. 2005
    ..Our results suggest the potential use of toluidine blue in identifying high-risk OPLs...
  21. ncbi Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis
    Graeme G Duncan
    Department of Radiation Oncology, British Columbia Cancer Agency, Vancouver Centre, 600 West 10th Ave, Vancouver, BC, Canada V6Z 4E6
    Head Neck 27:421-8. 2005
    ..We present the quality of life (QOL) analysis for this trial...
  22. ncbi Carcinogenesis and cyclooxygenase: the potential role of COX-2 inhibition in upper aerodigestive tract cancer
    Sivani Mohan
    Department of Oral Medicine, University of Washington, Seattle, WA, USA
    Oral Oncol 39:537-46. 2003
    ..COX-2 inhibitors may have a potential role in chemoprevention of UADT cancer, and clinical trials appear warranted...
  23. ncbi Current practice and knowledge of oral care for cancer patients: a survey of supportive health care providers
    Gerry J Barker
    Department of Dental Public Health and Behavioral Science School of Dentistry, University of Missouri Kansas City, 650 E 25th Street, Kansas City, MO 64108, USA
    Support Care Cancer 13:32-41. 2005
    ....
  24. ncbi Cancer-related oral health care services and resources: a survey of oral and dental care in Canadian cancer centres
    Joel B Epstein
    Department of Oral Medicine, and Diagnostic Sciences, College of Dentistry, University of Illinois, Chicago, Illinois 60612, USA
    J Can Dent Assoc 70:302-4. 2004
    ..The purpose of this survey was to assess the resources available for oral care in Canadian cancer centres...
  25. ncbi Topical polyene antifungals in hematopoietic cell transplant patients: tolerability and efficacy
    Joel B Epstein
    Department of Oral Medicine and Diagnostic Sciences, College of Dentistry, University of Illinois at Chicago, 801 S Paulina Street, Room 556, Chicago, IL 60612 7213, USA
    Support Care Cancer 12:517-25. 2004
    ..The effectiveness of amphotericin B oral suspension versus nystatin oral suspension for the prevention of oral colonization by Candida in hematopoietic cell transplant (HCT) patients was examined...
  26. ncbi Managing pain in mucositis
    Joel B Epstein
    Department of Oral Medicine and Diagnostic Sciences, College of Dentistry, Interdisciplinary Program in Oral Cancer, Chicago Cancer Center, Chicago, IL 60612, USA
    Semin Oncol Nurs 20:30-7. 2004
    ..To discuss pharmacologic and nonpharmacologic approaches available to manage pain...
  27. ncbi Assessment of the use of sialogogues in the clinical management of patients with xerostomia
    Nita Chainani-Wu
    Department of Orofacial Sciences, University of California, San Francisco, Calif, USA
    Spec Care Dentist 26:164-70. 2006
    ..The observed carryover effect suggests that intermittent treatment may be an alternative to continuous treatment with sialogogues...
  28. ncbi The efficacy of oral lumenoscopy (ViziLite) in visualizing oral mucosal lesions
    Joel B Epstein
    College of Dentistry and Illinois Cancer Center, University of Illinois, Chicago, Ill, USA
    Spec Care Dentist 26:171-4. 2006
    ..The chemiluminescent light did not appear to improve visualization of red lesions, but white lesions and lesions that were both red and white showed enhanced brightness and sharpness...
  29. pmc Screening for and diagnosis of oral premalignant lesions and oropharyngeal squamous cell carcinoma: role of primary care physicians
    Joel B Epstein
    Department of Oral Medicine and Diagnostic Sciences MC838, University of Illinois at Chicago, 801 S Paulina St, Room 56x, Chicago, IL 60612, USA
    Can Fam Physician 54:870-5. 2008
    ....
  30. doi Doxepin rinse for management of mucositis pain in patients with cancer: one week follow-up of topical therapy
    Joel B Epstein
    British Columbia Cancer Agency, Vancouver, British Columbia, Canada
    Spec Care Dentist 28:73-7. 2008
    ..05). These results indicate that doxepin rinsing continues to produce reduced intensity of pain levels over a 1-week span of repeated dosing...
  31. ncbi Oral malignancies associated with HIV
    Joel B Epstein
    Department of Oral Medicine and Diagnostic Sciences, College of Dentistry, University of Illinois at Chicago, Illinois 60091, USA
    J Can Dent Assoc 73:953-6. 2007
    ..Oral health care providers can identify these lesions early...
  32. ncbi Changes in the pattern of oral lesions associated with HIV infection: implications for dentists
    Herve Y Sroussi
    Department of Oral Medicine and Diagnostic Sciences and Chicago Cancer Center, University of Illinois at Chicago, Chicago, Illinois, USA
    J Can Dent Assoc 73:949-52. 2007
    ..Head and neck and oral examination coupled with a careful consideration of the complications associated with hyposalivation remain essential components of a comprehensive oral health care program...
  33. ncbi Management of patients who have undergone head and neck cancer therapy
    Dena J Fischer
    Department of Oral Medicine and Diagnostic Sciences, University of Illinois at Chicago College of Dentistry, 801 South Paulina Street, MC 838, Chicago, IL 60612 7213, USA
    Dent Clin North Am 52:39-60, viii. 2008
    ....
  34. ncbi A survey of the current approaches to diagnosis and management of oral premalignant lesions
    Joel B Epstein
    Department of Oral Medicine and Diagnostic Sciences, College of Dentistry, University of Illinois at Chicago, 801 S Paulina Street, Chicago, IL 60612, USA
    J Am Dent Assoc 138:1555-62; quiz 1614. 2007
    ..The authors conducted a study to identify current practices in the diagnosis and management of these oral lesions by oral medicine professionals...
  35. ncbi Utility of toluidine blue in oral premalignant lesions and squamous cell carcinoma: continuing research and implications for clinical practice
    Joel B Epstein
    Department of Oral Medicine and Diagnostic Sciences, College of Dentistry, University of Illinois, Chicago, Illinois, USA
    Head Neck 29:948-58. 2007
    ..The data supports TB use in oral examination of patients at risk of OSCC...
  36. ncbi Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire
    Joel B Epstein
    Department of Oral Medicine and Diagnostic Sciences, College of Dentistry and Chicago Cancer Center, University of Illinois, Chicago, Illinois 60612, USA
    Cancer 109:1914-22. 2007
    ..The OMWQ-HN is a patient-reported outcome questionnaire that measures the symptoms of mucositis, including mouth and throat soreness (MTS), and their impact on patient well-being and function...
  37. ncbi Management of pain in cancer patients with oral mucositis: follow-up of multiple doses of doxepin oral rinse
    Joel B Epstein
    J Pain Symptom Manage 33:111-4. 2007
  38. ncbi Assessment and measurement of oral mucositis
    June Eilers
    Department of Oncology Hematology, The Nebraska Medical Center, Omaha, NE, USA
    Semin Oncol Nurs 20:22-9. 2004
    ..To discuss the assessment and monitoring of mucositis and provide an overview of instruments available to assess or measure mucositis...
  39. ncbi The efficacy of pilocarpine and bethanechol upon saliva production in cancer patients with hyposalivation following radiation therapy
    Meir Gorsky
    School of Dental Medicine, Tel Aviv University, Israel
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97:190-5. 2004
    ..The purpose of the present study was to compare the efficacy of bethanechol to that of pilocarpine in patients with dry mouth following cancer therapy...
  40. ncbi Advances in the diagnosis of oral premalignant and malignant lesions
    Joel B Epstein
    Division of Dentistry, British Columbia Cancer Agency, Vancouver, Canada
    J Can Dent Assoc 68:617-21. 2002
    ..Oral health care providers should be aware of these advances in the evaluation and diagnosis of oral premalignant lesions and squamous cell carcinoma...
  41. ncbi Defining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis: oral mucositis patient provider advisory board
    Lisa A Bellm
    IntraBiotics Pharmaceuticals, Inc, 1245 Terra Bella Avenue, Mountain View, CA 94043, USA
    Cancer Invest 20:793-800. 2002
    ..Minimally, clinical trials for OM should assess oral pain, opioid use, oral intake, and include objective assessment of OM...
  42. ncbi Managing the oral sequelae of cancer therapy
    Georgia Robins Sadler
    University of California, San Diego School of Medicine, San Diego, CA, USA
    Medsurg Nurs 12:28-36. 2003
    ..Limiting the effects of oral sequelae increases patient adherence to treatment protocols, improves the quality of life, and increases the odds of long-term survival...
  43. ncbi Modified Delphi survey for decision analysis for prophylaxis of post-radiation osteonecrosis
    Carl K Cramer
    Department of Health Care and Epidemiology, University of British Columbia, 5804 Fairview Avenue, BC, Vancouver, Canada
    Oral Oncol 38:574-83. 2002
    ....
  44. ncbi Complications of radiation therapy for head and neck cancers. The patient's perspective
    Alison M Rose-Ped
    Empirica, Inc, Portland, Ore 97225, USA
    Cancer Nurs 25:461-7; quiz 468-9. 2002
    ..Trends toward more aggressive management of head and neck cancers underscore the need for new and effective therapies for oropharyngeal mucositis occurring in patients receiving radiotherapy...
  45. ncbi Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review
    Andy Trotti
    Radiation Oncology Program, H Lee Moffitt Cancer Center and Research Institute, University of South Florida, 12902 Magnolia Drive, Tampa, FL 33612, USA
    Radiother Oncol 66:253-62. 2003
    ..To determine the frequency of mucositis and associated outcomes in patients receiving radiotherapy (RT) for head and neck cancer through a systematic review of recently published literature...
  46. ncbi Antimicrobial therapy to prevent or treat oral mucositis
    J Peter Donnelly
    Supportive Care Studies, Department of Haematology, University Medical Centre, St Radboud, Nijmegen, Netherlands
    Lancet Infect Dis 3:405-12. 2003
    ..Hence, there is a need to better understand the role of the microflora in the cause of oral mucositis if an antimicrobial agent for prevention and treatment of this disease is to be developed...
  47. ncbi Oral lichen planus: progress in understanding its malignant potential and the implications for clinical management
    Joel B Epstein
    Department of Dentistry, Vancouver Hospital and Division of Hospital Dentistry, University of British Columbia, Canada
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96:32-7. 2003
    ..Dysplastic OLP may be best treated as other oral dysplastic conditions; thus, regular, more frequent follow-up is required...
  48. ncbi Oral candidiasis in hematopoietic cell transplantation patients: an outcome-based analysis
    Joel B Epstein
    Department of Oral Medicine and Diagnostic Sciences, University of Illinois, Chicago, USA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96:154-63. 2003
    ..The objectives of this study were to examine the relationship of oral colonization by Candida species to systemic infection, mortality, and the impact of antifungal treatment on a population of recipients of HCT...
  49. ncbi Increased allelic loss in toluidine blue-positive oral premalignant lesions
    Joel B Epstein
    University of British Columbia, Vancouver, Canada
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95:45-50. 2003
    ..This preliminary study investigated whether the dye toluidine blue (TB) preferentially stains oral premalignant lesions with LOH. This stain has been used by clinicians to delineate dysplasia/carcinoma in the oral cavity...
  50. ncbi Intraoral melanoma: long-term follow-up and implication for dental clinicians. A case report and literature review
    Gao Man Gu
    Department of Oral Medicine, School of Dentistry, University of Washington, Seattle 98195, USA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96:404-13. 2003
    ..Dental clinicians should conduct a thorough head, neck, and oral follow-up with increased vigilance in patients with a history of prior cancer...
  51. ncbi The utility of tolonium chloride rinse in the diagnosis of recurrent or second primary cancers in patients with prior upper aerodigestive tract cancer
    Joel B Epstein
    Division of Dentistry, British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia V5Z 4E6 Canada
    Head Neck 25:911-21. 2003
    ..The clinical utility of tolonium chloride rinse was compared with unaided visual examination alone in the diagnosis of oral carcinoma in patients previously treated for carcinoma of the upper aerodigestive tract...
  52. ncbi Oral and dental management related to radiation therapy for head and neck cancer
    Pamela J Hancock
    Department of Oral Medicine, University of Washington, Seattle, USA
    J Can Dent Assoc 69:585-90. 2003
    ..In addition, it reviews considerations for continued treatment needs during the patient"s lifetime...
  53. ncbi Interobserver reliability in the histopathologic diagnosis of oral pre-malignant and malignant lesions
    Dena J Fischer
    Department of Oral Medicine, School of Dentistry, Box 356370, University of Washington, Seattle, WA 98195 6370, USA
    J Oral Pathol Med 33:65-70. 2004
    ..The histologic classification of pre-cancerous and cancerous oral lesions has generally shown poor agreement between pathologists, but lesion and patient characteristics that may affect diagnostic reliability have not been explored...
  54. ncbi Oropharyngeal mucositis in cancer therapy. Review of pathogenesis, diagnosis, and management
    Joel B Epstein
    Department of Oral Medicine and Diagnostic Sciences, College of Dentistry, University of Illinois, Program in Oral Cancer, College of Medicine, Chicago Cancer Center, Chicago, Illinois, USA
    Oncology (Williston Park) 17:1767-79; discussion 1779-82, 1791-2. 2003
    ..Continuing research related to the pathogenesis and management of mucositis will undoubtedly lead to the development of potential interventions and improved patient care...
  55. ncbi Cost of care for early- and late-stage oral and pharyngeal cancer in the California Medicaid population
    Joshua D Epstein
    Department of Pharmaceutical Economics and Policy, University of Southern California, Los Angeles, California, USA
    Head Neck 30:178-86. 2008
    ..This study documents the direct medical costs associated with treating oral and pharyngeal squamous cell carcinoma (OSCC) as early- or late-stage disease according to the current standard of care...
  56. ncbi In vivo optical coherence tomography-based scoring of oral mucositis in human subjects: a pilot study
    Hilari Kawakami-Wong
    University of California, Irvine, Beckman Laser Institute, 1002 Health Sciences Road East, Irvine, California 92612, USA
    J Biomed Opt 12:051702. 2007
    ..Chemotherapy-induced oral changes were identified prior to their clinical manifestation using OCT, and the proposed scoring system for oral mucositis was validated for the semiquantification of mucositic change...
  57. ncbi Intralesional chemotherapy for head and neck carcinoma: a review of the literature
    Andrei Barasch
    Dept of Diagnostic Sciences, University of Detroit Mercy School of Dentistry, MI 48219 0900, USA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97:307-11. 2004
    ..We review this literature with the objective of popularizing these data and suggesting future directions for treatment and clinical research for head and neck cancer...
  58. ncbi Periodontal infection in cancer patients treated with high-dose chemotherapy
    Judith E Raber-Durlacher
    Department of Clinical Oncology, University Medical Center, The Netherlands
    Support Care Cancer 10:466-73. 2002
    ..Furthermore, a multidisciplinary approach to the management of periodontal infections and the need for future research is discussed...
  59. ncbi Valacyclovir versus acyclovir for HSV prophylaxisin neutropenic patients
    Dawn I Warkentin
    Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada
    Ann Pharmacother 36:1525-31. 2002
    ..Valacyclovir has greater oral bioavailability and requires less frequent dosing...
  60. ncbi Taste change associated with a dental procedure: case report and review of the literature
    Gary D Klasser
    Department of Oral Medicine and Diagnostic Sciences, University of Illinois at Chicago College of Dentistry, 801 South Paulina Street, Room 569B M C 838, Chicago, IL 60612 7213, USA
    J Can Dent Assoc 74:455-61. 2008
    ..The case is presented to enhance understanding of taste disorders and their relation to a localized traumatic event. Causative factors and management strategies are also reviewed...
  61. ncbi Infectious hepatitis C, hepatitis G, and TT virus: review and implications for dentists
    Giovanni Lodi
    Department of Oral Medicine, Eastman Dental Institute for Oral Health Care Sciences, University of London, UK
    Spec Care Dentist 22:53-8. 2002
    ..Dental providers will see a growing number of patients with HCV/HGV and possibly TTV infection. All of these patients require appropriate infection control measures during dental treatment...
  62. doi Budesonide for local therapy of complex oral mucosal immune-mediated inflammatory diseases: case reports
    Robert A Utsman
    Department of Oral Medicine and Diagnostic Sciences, University of Illinois at Chicago, College of Dentistry, Chicago, IL 60612, USA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106:e11-7. 2008
    ..The cases presented represent mucosal conditions that were successfully managed with topical application of budesonide with reduced risk of systemic effects...
  63. ncbi Radiographic and clinical features of temporomandibular dysfunction in patients following indirect trauma: a retrospective study
    Miriam Grushka
    Department of Surgery, William Osler Health Center, Toronto, ON, Canada
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104:772-80. 2007
    ....
  64. ncbi Proliferative verrucous leukoplakia and its progression to oral carcinoma: report of three cases
    Thomas H Morton
    Department of Oral Biology, School of Dentistry, University of Washington, Seattle, WA, USA
    J Oral Pathol Med 36:315-8. 2007
    ..We present three cases of PVL that progressed to carcinoma and discuss the histopathologic findings that may either hinder or assist in the diagnosis...
  65. ncbi Proliferative verrucous leukoplakia and its progression to oral carcinoma: a review of the literature
    Robert J Cabay
    Department of Pathology, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612 7213, USA
    J Oral Pathol Med 36:255-61. 2007
    ..PVL behaves in a more aggressive and relentless manner than the more innocuous white oral lesions that it can resemble clinically...
  66. ncbi Carcinoma of the tongue: a case series analysis of clinical presentation, risk factors, staging, and outcome
    Meir Gorsky
    The Maurice and Gabriela Goldschleger School of Dental Medicine, Tel Aviv University, Tel Aviv, Israel
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98:546-52. 2004
    ..The tongue is the most common site of oral cancer. Oropharyngeal cancer accounts for approximately 2% of all cancer deaths. The purpose of this study was to analyze a case series of patients with tongue cancer...
  67. ncbi Diabetes mellitus: an updated overview of medical management and dental implications
    Keerthi Golla
    Department of Oral Medicine and Diagnostic Sciences, College of Dentistry, University of Illinois, Chicago, USA
    Gen Dent 52:529-35; quiz 536, 527-8. 2004
    ..Dental providers must be aware of the rapid changes concerning management of individuals with DM and must understand the significant impact DM has on dental treatment...
  68. ncbi Oral malignancies in HIV disease: changes in disease presentation, increasing understanding of molecular pathogenesis, and current management
    Joel B Epstein
    Department of Oral Medicine and Diagnostic Sciences, College of Dentistry, Chicago Cancer Center, University of Illinois at Chicago, IL 60612USA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100:571-8. 2005
    ..This paper discusses recent trends in the presentation and treatment of malignancies related to HIV and AIDS with an emphasis on malignancies seen in the oral cavity...
  69. ncbi Microarrays and clinical dentistry
    Winston Patrick Kuo
    Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, Mass 02115, USA
    J Am Dent Assoc 134:456-62. 2003
    ....
  70. ncbi Current surgical treatment of squamous cell carcinoma of the head and neck
    Mike Yao
    University of Illinois at Chicago, Department of Otolaryngology, 1855 W Taylor Street, M C 648, Chicago, IL 60612, United States
    Oral Oncol 43:213-23. 2007
    ..Oral care providers must be aware of advances in cancer management and implications for patient care to effectively care for these patients...
  71. ncbi Hyposalivation in elderly patients
    Anurag Gupta
    Department of Oral Medicine and Diagnostic Sciences, MC 838, 801 South Paulina St, University of Illinois at Chicago, Chicago, IL 60091, USA
    J Can Dent Assoc 72:841-6. 2006
    ..In this paper, we review the causes of dry mouth and its impact on health. The role of dental providers and current management of dry mouth is presented...
  72. ncbi The methamphetamine epidemic and dentistry
    Gary D Klasser
    Department of Oral Medicine and Diagnostic Sciences, College of Dentistry, University of Illinois, Chicago, USA
    Gen Dent 54:431-9; quiz 440, 448. 2006
    ....
  73. ncbi Fetal alcohol syndrome: case report and review of the literature
    Anut Itthagarun
    Pediatric Dentistry, School of Dentistry and Oral Health, Griffith University, Gold Coast, Australia
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103:e20-5. 2007
    ..This article reviews the prevalence, incidence, alcohol dose response and metabolism, and clinical characteristics of FAS. A case demonstrating moderate signs of the condition is included to illustrate some of the characteristics...
  74. ncbi Updated clinical practice guidelines for the prevention and treatment of mucositis
    Dorothy M Keefe
    Department of Medical Oncology, Royal Adelaide Hospital, Adelaide, Australia
    Cancer 109:820-31. 2007
    ..These efforts are likely to have significant clinical and economic impact on the treatment of cancer patients. Cancer 2007;109:820-31. (c) 2007 American Cancer Society...
  75. ncbi Management of oral epithelial dysplasia: a review
    Michael Brennan
    Carolinas Medical Center, Charlotte, NC, USA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103:S19.e1-12. 2007
    ..Because of the lack of randomized controlled trials that have shown effectiveness in the prevention of malignant transformation, no recommendations can be provided for specific surgical interventions of dysplastic oral lesions either...
  76. ncbi The prevalence of herpes simplex virus shedding and infection in the oral cavity of seropositive patients undergoing head and neck radiation therapy
    Joel B Epstein
    University of Washington, Seattle, USA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94:712-6. 2002
    ..The purpose of the present study was to evaluate the incidence of HSV reactivation in patients receiving radiation treatment for head and neck malignancies...
  77. ncbi Adjunctive techniques for oral cancer examination and lesion diagnosis: a systematic review of the literature
    Lauren L Patton
    Department of Dental Ecology, General Practice Residency Program, School of Dentistry, University of North Carolina Chapel Hill, Chapel Hill, NC 27599 7450, USA
    J Am Dent Assoc 139:896-905; quiz 993-4. 2008
    ..Adjunctive techniques that may facilitate the early detection of oral premalignant and malignant lesions (OPML) have emerged in the past decades...